Results 211 to 220 of about 18,181 (226)
Some of the next articles are maybe not open access.
Friction in the Path to Use of Biosimilar Drugs
New England Journal of Medicine, 2018Richard G. Frank
exaly
Analytical Similarity Assessment of Rituximab Biosimilar CT-P10 to Reference Medicinal Product
MAbs, 2018Jin Soo Bae, Jung Woo Lee, Jihun Lee
exaly
Analytical and Functional Similarity of Amgen Biosimilar ABP 215 to Bevacizumab
MAbs, 2018Scott Kuhns, Neungseon Seo, Jennifer Liu
exaly
Rationale, Opportunities, and Reality of Biosimilar Medications
New England Journal of Medicine, 2018Gary Lyman +2 more
exaly
Regulation of Biosimilar Medicines and Current Perspectives on Interchangeability and Policy
European Journal of Clinical Pharmacology, 2019Brendan T. Griffin
exaly
Japanese Regulation of Biosimilar Products: Past Experience and Current Challenges
British Journal of Clinical Pharmacology, 2016Teruyo Arato
exaly

